Linked Data API

Show Search Form

Search Results

731081
star this property registered interest false more like this
unstar this property date less than 2017-06-21more like thismore than 2017-06-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text Her Majesty's Government how many NHS staff members are from (1) EU member states other than the UK, and (2) countries outside the EU. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL89 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-07-04more like thismore than 2017-07-04
star this property answer text <p>NHS Digital publishes data on the nationality of staff working in the National Health Service in England. Nationality is self-reported within the NHS human resources and payroll system, the electronic staff record.</p><p>As of 31 March 2017, latest data available, there are now 61,934 (headcount) European Union nationals (excluding the United Kingdom), or 5.2% employed in the NHS trusts and clinical commissioning groups. There are 75,450 other overseas nationals, or 6.4% employed in the NHS. 80,822 NHS staff records do not contain nationality data, with people either choosing not to specify their nationality or not asked to.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-07-04T15:50:03.01Zmore like thismore than 2017-07-04T15:50:03.01Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
804237
star this property registered interest false more like this
unstar this property date less than 2017-12-11more like thismore than 2017-12-11
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Health Professions: Training more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how they plan to train additional medical staff from the UK to replace existing staff from other EU countries who have left or might leave the NHS. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL4058 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-12-22more like thismore than 2017-12-22
star this property answer text <p>In October 2016, the Government announced a historic expansion of medical school places increasing medical school places in England by 1,500. The first 500 places have already been allocated and will be available to students in September 2018. The remaining 1,000 additional medical school places would be available to medical schools in England via a competitive bidding process managed jointly by the Higher Education Funding Council for England and Health Education England.</p><p> </p><p>We have also announced a 25% increase in nurse training places to provide at least 5,000 extra nurse training places every year from 2018/19 - 25,850 from 2018/19 compared to 20,680 in 2016/17.</p><p> </p><p>National Health Service workforce training in Northern Ireland, Scotland and Wales are matters for the devolved administrations in each of those countries.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-12-22T12:44:31.873Zmore like thismore than 2017-12-22T12:44:31.873Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
1050833
star this property registered interest false more like this
unstar this property date less than 2019-01-29more like thismore than 2019-01-29
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Radioisotopes more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how they will ensure the supply of radiopharmaceuticals in the event of a no-deal Brexit; and what steps they will take to prevent delays in the treatment of patients with serious conditions. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL13253 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-02-11more like thismore than 2019-02-11
star this property answer text <p>The Department understand that diabetes medicines and medical radiopharmaceuticals are vitally important to many people in this country. Our ‘no deal’ contingency plans include mitigations for medicines that come to the United Kingdom from or via the European Union or European Economic Area (EEA), including precautionary stockpiling by suppliers and securing alternative shipping routes to ensure the flow of medicines, to ensure that the supply of diabetes medicines, medical radioisotopes and other essential medicines to patients is not disrupted.</p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p>We recognise that certain medicines with short shelf lives, including medical radiopharmaceuticals or medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure that they have plans in place in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>While the stockpiling medicines and alternative air freight remains a critical part of our ‘no deal’ medicine supply contingency plans, we are also supplementing these with additional actions.</p><p>We are working towards ensuring we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely in to the UK. Medicines and medical products, including diabetes medicines, will be prioritised on these routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p>Throughout enacting our plans, we have received very good engagement from industry who share our aims of ensuring that the continuity of supply of medicines and medical products for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN
HL13252 more like this
HL13254 more like this
star this property question first answered
less than 2019-02-11T17:57:28.29Zmore like thismore than 2019-02-11T17:57:28.29Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
930930
star this property registered interest false more like this
unstar this property date less than 2018-06-25more like thismore than 2018-06-25
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medicine: Research more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how they will protect joint projects with EU member states into disabilities and diseases if the UK leaves the EU. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL8930 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-07-09more like thismore than 2018-07-09
star this property answer text <p>We want to continue to cooperate closely with our European partners to the benefit of all citizens and patients in the United Kingdom and across the European Union. As part of this, we are determined to continue working closely with health ministers across the EU and the European Commission and Parliament on a wide variety of issues including disabilities and diseases. Whilst we cannot pre-empt the negotiations, nor can we disadvantage the UK’s position in these negotiations by giving inappropriate guarantees at this time, the Government will continue to seek the best possible deal for the UK.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-07-09T10:43:10.603Zmore like thismore than 2018-07-09T10:43:10.603Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
768561
star this property registered interest false more like this
unstar this property date less than 2017-10-11more like thismore than 2017-10-11
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Health Services: Foreign Nationals more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of the extent to which the changes brought in by National Health Service (Charges to Overseas Visitors) (Amendment) Regulations 2017 may exacerbate health inequalities; whether they have made any further estimate of the savings to be made since publishing their impact assessment; if so, what is the difference between those two estimates; and whether they plan to reconsider those changes. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL1911 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-10-18more like thismore than 2017-10-18
star this property answer text <p>Following a detailed public consultation that ran from December 2015 to March 2016, the Government set out in its response to that consultation in February 2017 that it intended to amend the existing Charging Regulations. Over the course of the consultation and decision-making process, the Government carefully considered the impact the changes may have on public health, health inequalities and on vulnerable groups. The regulations providing for these changes were introduced on 19 July 2017 alongside a published impact assessment which estimated that the net income per annum as a result of the new regulations would be up to £40 million per year. While the Government monitors the implementation of the regulations and their effects, no further estimates on the net income have been made since the publication of the impact assessment.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-10-18T09:36:33.43Zmore like thismore than 2017-10-18T09:36:33.43Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
850572
star this property registered interest false more like this
unstar this property date less than 2018-02-27more like thismore than 2018-02-27
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of why flash glucose monitors are available to patients in some parts of England and not in others. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL5916 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-13more like thismore than 2018-03-13
star this property answer text <p>Freestyle Libre, the flash glucose monitoring system was included in Part IX of the England and Wales Drug Tariff from November 2017. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free National Health Service prescriptions if they hold a valid medical exemption certificate. However, patients will need to discuss the ongoing management of their condition with their healthcare professional and consider what is most suitable for them.</p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p><p>Reducing variation in the management and care of people with diabetes by 2020 is an objective included in the NHS England mandate. The NHS RightCare diabetes pathway shows the core components of an optimal diabetes service, as well as evidence of the opportunity to reduce variation. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free NHS prescriptions if they hold a valid medical exemption certificate.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN
HL5914 more like this
HL5915 more like this
star this property question first answered
less than 2018-03-13T15:47:25.943Zmore like thismore than 2018-03-13T15:47:25.943Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
1050831
star this property registered interest false more like this
unstar this property date less than 2019-01-29more like thismore than 2019-01-29
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what commitments they will make to ensure that the UK's 3.7 million diagnosed diabetics will have access to sufficient stockpiles of medication to avoid potential deaths from diabetic ketoacidosis in the event of a no-deal Brexit. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL13252 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-02-11more like thismore than 2019-02-11
star this property answer text <p>The Department understand that diabetes medicines and medical radiopharmaceuticals are vitally important to many people in this country. Our ‘no deal’ contingency plans include mitigations for medicines that come to the United Kingdom from or via the European Union or European Economic Area (EEA), including precautionary stockpiling by suppliers and securing alternative shipping routes to ensure the flow of medicines, to ensure that the supply of diabetes medicines, medical radioisotopes and other essential medicines to patients is not disrupted.</p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p>We recognise that certain medicines with short shelf lives, including medical radiopharmaceuticals or medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure that they have plans in place in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>While the stockpiling medicines and alternative air freight remains a critical part of our ‘no deal’ medicine supply contingency plans, we are also supplementing these with additional actions.</p><p>We are working towards ensuring we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely in to the UK. Medicines and medical products, including diabetes medicines, will be prioritised on these routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p>Throughout enacting our plans, we have received very good engagement from industry who share our aims of ensuring that the continuity of supply of medicines and medical products for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN
HL13253 more like this
HL13254 more like this
star this property question first answered
less than 2019-02-11T17:57:28.227Zmore like thismore than 2019-02-11T17:57:28.227Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
1122909
star this property registered interest false more like this
unstar this property date less than 2019-04-24more like thismore than 2019-04-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading British Nationals Abroad: EU Countries more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what guarantees, if any, they have made of the healthcare benefits available to British citizens residing in EU countries post-Brexit. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL15300 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-09more like thismore than 2019-05-09
star this property answer text <p>Subject to Parliament ratifying the Withdrawal Agreement, in a deal scenario current reciprocal healthcare rights will continue during the implementation period until 31 December 2020. The Withdrawal Agreement and European Free Trade Area (EFTA) Agreements also give longer-term reciprocal healthcare rights to those who are living in or previously worked in the other country on exit day.</p><p>Further to this, on 19 March 2019 I laid a written statement (HLWS1396) outlining the Department’s plans for the continuity of reciprocal healthcare arrangements in the event we exit the European Union without a deal. This statement includes specific guidance for United Kingdom nationals residing in EU countries post-exit.</p><p>The UK has proposed to EU Member States and EFTA states that we should maintain the existing healthcare arrangements, in the event of the UK leaving the EU without a deal up until 31 December 2020.</p><p>As well as seeking an extension of the current arrangements, we have made a guarantee to EU member states that we will reimburse Member States for treatments that were ongoing on exit day, for up to one year where this is necessary.</p><p>This guarantee requires reciprocity from the EU or individual Member States and cannot be implemented unilaterally. The UK Government is seeking agreements with Member States, so that no individual, including UK nationals living in other EU Member States, will face sudden changes to their healthcare cover. These discussions are ongoing.</p><p>The Government has brought forward legislation to enable us to implement new reciprocal healthcare arrangements. The Healthcare (European Economic Area and Switzerland Arrangements) Act received Royal Assent on 26 March 2019 and will provide us with the power to fund and implement comprehensive reciprocal healthcare arrangements after we leave the EU. We have also laid three Statutory Instruments which will give us the specific legal basis to implement our proposal.</p><p>General information is available online on the GOV.UK website and country-specific advice can be found under the relevant sections of NHS.UK.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-09T13:10:09.81Zmore like thismore than 2019-05-09T13:10:09.81Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
908918
star this property registered interest false more like this
unstar this property date less than 2018-05-21more like thismore than 2018-05-21
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what measures are in place to ensure equitable access to (1) insulin pumps, and (2) other diabetes technologies, across England. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL8080 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-06-05more like thismore than 2018-06-05
star this property answer text <p>Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines. This should include consideration of access to insulin pumps and other diabetes technologies for people with diabetes who might benefit from them.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-06-05T15:55:33.68Zmore like thismore than 2018-06-05T15:55:33.68Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this
874611
star this property registered interest false more like this
unstar this property date less than 2018-03-29more like thismore than 2018-03-29
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have for the long-term approach to diabetes. more like this
star this property tabling member printed
Lord Roberts of Llandudno remove filter
unstar this property uin HL6831 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-16more like thismore than 2018-04-16
star this property answer text <p>The long-term approach to diabetes involves both seeking to reduce the increase in the prevalence of diabetes and, for those with diabetes, seeking to reduce the likelihood of developing complications and improving overall levels of treatment and care.</p><p>Work to reduce the increase in future prevalence of type 2 diabetes is being delivered through the NHS Diabetes Prevention Programme. By 2020, the programme will support up to 100,000 people at high risk of type 2 diabetes each year across England. Those referred will get tailored, personalised support over at least nine months to achieve a healthy weight, improve nutrition and increase levels of physical activity in order to reduce risks of developing type 2 diabetes.</p><p>Work on reducing the likelihood of those with diabetes developing complications is through the diabetes treatment and care programme. This focuses on four key interventions:</p><p>- Increasing attendance at structured education by both those newly diagnosed with diabetes and those who have had the condition for a longer period;</p><p>- Increasing achievement of the diabetes treatment targets and reducing variation in achievement of these targets between clinical commissioning groups and between general practitioner practices;</p><p>- Reducing the levels of amputations by increasing the availability of multidisciplinary footcare teams; and</p><p>- Reducing lengths of inpatient stay for people with diabetes by increasing the availability of diabetes inpatient specialist nurses.</p><p> </p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-04-16T14:02:32.23Zmore like thismore than 2018-04-16T14:02:32.23Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno more like this